Odontogenic sinusitis: A state-of-the-art review

来源 :世界耳鼻咽喉头颈外科杂志(英文) | 被引量 : 0次 | 上传用户:liongliong541
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Odontogenic sinusitis (ODS) is more common than historically reported, and is under-represented in the sinusitis literature. ODS is distinct from rhinosinusitis in that it is infectious sinusitis from an infectious dental source or a complication from dental procedures, and most commonly presents unilaterally. ODS clinical features, microbiology, and diagnostic and treatment paradigms are also distinct from rhinosinusitis. ODS evaluation and management should generally be conducted by both otolaryngologists and dental providers, and clinicians must be able to suspect and confirm the condition. ODS suspicion is driven by certain clinical features like unilateral maxillary sinus opacification on computed tomography, overt maxillary dental pathology on computed tomography, unilateral middle meatal purulence on nasal endoscopy, foul smell, and odontogenic bacteria in sinus cultures. Otolaryngologists should confirm the sinusitis through nasal endoscopy by assessing for middle meatal purulence, edema, or polyps. Dental providers should confirm dental pathology through appropriate examinations and imaging. Once ODS is confirmed, a multidisciplinary shared decision-making process should ensue to discuss risks and benefits of the timing and different types of dental and sinus surgical interventions. Oral antibiotics are generally ineffective at resolving ODS, especially when there is treatable dental pathology. When both the dental pathology and sinusitis are addressed, resolution can be expected in 90%-100% of cases. For treatable dental pathology, while primary dental treatment may resolve the sinusitis, a significant percentage of patients still require endoscopic sinus surgery. For patients with significant sinusitis symptom burdens, primary endoscopic sinus surgery is an option to resolve symptoms faster, followed by appropriate dental management. More well-designed studies are necessary across all areas of ODS.“,”Odontogenic sinusitis (ODS) is more common than historically reported, and is under-represented in the sinusitis literature. ODS is distinct from rhinosinusitis in that it is infectious sinusitis from an infectious dental source or a complication from dental procedures, and most commonly presents unilaterally. ODS clinical features, microbiology, and diagnostic and treatment paradigms are also distinct from rhinosinusitis. ODS evaluation and management should generally be conducted by both otolaryngologists and dental providers, and clinicians must be able to suspect and confirm the condition. ODS suspicion is driven by certain clinical features like unilateral maxillary sinus opacification on computed tomography, overt maxillary dental pathology on computed tomography, unilateral middle meatal purulence on nasal endoscopy, foul smell, and odontogenic bacteria in sinus cultures. Otolaryngologists should confirm the sinusitis through nasal endoscopy by assessing for middle meatal purulence, edema, or polyps. Dental providers should confirm dental pathology through appropriate examinations and imaging. Once ODS is confirmed, a multidisciplinary shared decision-making process should ensue to discuss risks and benefits of the timing and different types of dental and sinus surgical interventions. Oral antibiotics are generally ineffective at resolving ODS, especially when there is treatable dental pathology. When both the dental pathology and sinusitis are addressed, resolution can be expected in 90%-100% of cases. For treatable dental pathology, while primary dental treatment may resolve the sinusitis, a significant percentage of patients still require endoscopic sinus surgery. For patients with significant sinusitis symptom burdens, primary endoscopic sinus surgery is an option to resolve symptoms faster, followed by appropriate dental management. More well-designed studies are necessary across all areas of ODS.
其他文献
传闻2rn公司引进国资战投进展顺利,价格基本谈妥.rn求证:不属实.rn日前,有网友向启明星辰(002439)提问:“听闻公司引进国资战投进展顺利,价格基本谈妥,请问是否属实?”rn对此,启明星辰进行了否认.
期刊
从目前的技术面上看,无论是沪市还是深市,均已进入熊市的技术格局.至于最惨的创业板指数,至今仍无任何反弹,一路下跌.春节后,沪指开始出现超跌反弹,甚至权重蓝筹股都开始出来护盘,但无奈“猪队友”创业板指数两次三番地被CRO、锂电、光伏去年最强的三个板块轮流暴跌带崩.
期刊
CXO即医药外包,是受制药企业或者生物科技公司委托,为其提供药物研发、生产工艺开发、药物生产、药物销售等服务的过程.CXO 主要包括 CRO(研发注册外包)、CMO/CDMO(生产工艺外包)、CSO(销售外包)三大环节.
期刊
Objectives::To demonstrate three-hundred and sixty degrees of maxillary sinus (MS) surgical approaches using cadaveric dissections, highlighting the step-by-step anatomy of each procedure.Methods::Two latex-injected cadaveric specimens were utilized to pe
A股市场最近风雨飘摇,新能源、医药排队被重锤,茅指数、宁组合也是风光不再,美女股神葛兰因重仓股频繁踩雷也被骂成了葛大妈.开年至今,创业板指已经下跌17.34%,深圳成指则下跌了11%,连沪深300都下跌了6.86%.指数全面下挫,多数公募基金的净值也是蹭蹭下跳,医药和新能源跌得鼻青脸肿,曾经的小甜甜成为了牛夫人.
期刊
在基金投资市场中,没有永远的低谷,也没有永远的盈利,前期被热捧的产品在后一秒就可能跌下神坛,而之前默默无闻的产品有可能接棒坐上宝座.变幻莫测才是证券投资市场最真实的底色.比起谁“笑得最好”,如今的基金投资者越来越关注谁能“笑到最后”.那么在最近三年,哪家基金收益最高?
期刊
股市中,新手与老手有很大的差别,入市前三五年是一个学习证券、金融、财务知识时期.炒股前五年,勤奋者基本上都能将这些基础知识学完,若是特别勤奋者,在此之上还可能自己有了方法总结.
期刊
随着新型冠状病毒肺炎的爆发和各种城市危机的出现,各行各业都引起了对城市规划和城市设计的思考。文章首先进行阐述了韧性城市的基本概念及发展理念文化内涵,并比较传统城市与韧性城市的区别,其次对西安市韧性城市的建设进行分析和总结,结合城市规划建设提出目前城市设计的部分问题,有利于促成城市设计理念和城市规划建设的实施。
Objective::Endoscopic approaches for sinus and skull base surgery are increasing in popularity. The objective of this narrative review is to characterize risk factors for internal carotid artery injury in endoscopic endonasal surgery (EES), highlight prev
湖北东田微科技股份有限公司(以下简称“东田微”)是一家从事精密光电薄膜元件研发、生产和销售的高新技术企业,公司主要产品为摄像头滤光片、光通信元件等,应用于消费类电子产品、车载摄像头、安防监控设备以及光通信信号传输、数据中心等终端领域.
期刊